bibtype |
J -
Journal Article
|
ARLID |
0565800 |
utime |
20240103231038.2 |
mtime |
20221221235959.9 |
SCOPUS |
85138444993 |
WOS |
000824508800001 |
DOI |
10.1093/infdis/jiac258 |
title
(primary) (eng) |
Reply to Llibre et al |
specification |
page_count |
1 s. |
media_type |
P |
|
serial |
ARLID |
cav_un_epca*0253827 |
ISSN |
0022-1899 |
title
|
Journal of Infectious Diseases |
volume_id |
226 |
volume |
5 (2022) |
page_num |
941-941 |
publisher |
name |
Oxford University Press |
|
|
keyword |
RNA vaccines |
keyword |
vaccine-specific analyses |
keyword |
Letter to the Editor |
author
(primary) |
ARLID |
cav_un_auth*0101206 |
name1 |
Šmíd |
name2 |
Martin |
institution |
UTIA-B |
full_dept (cz) |
Ekonometrie |
full_dept (eng) |
Department of Econometrics |
department (cz) |
E |
department (eng) |
E |
garant |
K |
fullinstit |
Ústav teorie informace a automatizace AV ČR, v. v. i. |
|
author
|
ARLID |
cav_un_auth*0270143 |
name1 |
Berec |
name2 |
L. |
country |
CZ |
|
author
|
ARLID |
cav_un_auth*0091778 |
name1 |
Trnka |
name2 |
J. |
country |
CZ |
|
source |
|
cas_special |
abstract
(eng) |
The letter by Llibre et al states that our study lacks a comparison between individual vaccines, so the authors present their own research on this topic, showing superiority of messenger RNA vaccines over adenovirus-based vaccines. |
result_subspec |
WOS |
RIV |
BC |
FORD0 |
10000 |
FORD1 |
10100 |
FORD2 |
10102 |
reportyear |
2023 |
num_of_auth |
3 |
inst_support |
RVO:67985556 |
permalink |
https://hdl.handle.net/11104/0337921 |
confidential |
S |
mrcbC91 |
C |
mrcbT16-e |
IMMUNOLOGY|INFECTIOUSDISEASES|MICROBIOLOGY |
mrcbT16-j |
2.208 |
mrcbT16-s |
2.386 |
mrcbT16-D |
Q1 |
mrcbT16-E |
Q1* |
arlyear |
2022 |
mrcbU14 |
85138444993 SCOPUS |
mrcbU24 |
PUBMED |
mrcbU34 |
000824508800001 WOS |
mrcbU63 |
cav_un_epca*0253827 Journal of Infectious Diseases 0022-1899 1537-6613 Roč. 226 č. 5 2022 941 941 Oxford University Press |
|